IN2013MU03765A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03765A
IN2013MU03765A IN3765MU2013A IN2013MU03765A IN 2013MU03765 A IN2013MU03765 A IN 2013MU03765A IN 3765MU2013 A IN3765MU2013 A IN 3765MU2013A IN 2013MU03765 A IN2013MU03765 A IN 2013MU03765A
Authority
IN
India
Prior art keywords
atorvastatin calcium
compositions
density lipoprotein
lipoprotein cholesterol
faster
Prior art date
Application number
Other languages
English (en)
Inventor
Gayatri Chhaganbhai Patel
Manali Manubhai Malaviya
Akash Rajendrakumar Patel
Brijesh Vallabhbhai Navadiya
Original Assignee
Charotar University Of Science & Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Charotar University Of Science & Technology filed Critical Charotar University Of Science & Technology
Priority to IN3765MU2013 priority Critical patent/IN2013MU03765A/en
Publication of IN2013MU03765A publication Critical patent/IN2013MU03765A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN3765MU2013 2013-11-30 2013-11-30 IN2013MU03765A (https=)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3765MU2013 IN2013MU03765A (https=) 2013-11-30 2013-11-30

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3765MU2013 IN2013MU03765A (https=) 2013-11-30 2013-11-30

Publications (1)

Publication Number Publication Date
IN2013MU03765A true IN2013MU03765A (https=) 2015-07-31

Family

ID=54398014

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3765MU2013 IN2013MU03765A (https=) 2013-11-30 2013-11-30

Country Status (1)

Country Link
IN (1) IN2013MU03765A (https=)

Similar Documents

Publication Publication Date Title
NZ780890A (en) Pharmaceutical compositions comprising meloxicam
NZ631100A (en) Soft chewable pharmaceutical products
CY1122626T1 (el) Κορτικοστεροειδες που περιεχει τις συνθεσεις των δισκιων που διασπωνται απο το στομα για την ηωσινοφιλικη οισοφαγιτιδα
EA201892395A1 (ru) Лекарственные составы ингибитора lsd1
MY178082A (en) Solid pharmaceutical compositions and processes for their production
WO2010127345A3 (en) Orally disintegrating tablet compositions comprising combinations of high and low-dose drugs
EA201500365A1 (ru) Комбинация регорафениба и ацетилсалициловой кислоты для лечения рака
MX2017010280A (es) Complejos de acetato de abiraterona, proceso para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
HK1215191A1 (zh) 低剂量医药组合物
WO2019155416A3 (en) A stable pharmaceutical composition of poorly soluble nonsteroidal antiandrogens
WO2014016754A3 (en) Pharmaceutical compositions of proton pump inhibitor
WO2012116176A3 (en) Asymmetric ureas and medical uses thereof
WO2011151722A3 (en) Methods and compositions for oral pharmaceutical therapy
PH12015500823A1 (en) Modified release formulations for oprozomib
PH12015500395A1 (en) Pharmaceutical composite capsule formulation comprising irbesartan and hmg-coa reductase inhibitor
EP3615011A4 (en) PHARMACEUTICAL COMPOSITION FOR IN VIVO ADMINISTRATION, PROCESS FOR THE PREPARATION OF A PHARMACOLOGICALLY ACTIVE PRINCIPLE SENSITIVELY INSOLUBLE IN WATER
WO2011083402A3 (en) Immediate release compositions of acid labile drugs
MX2015007731A (es) Formulacion farmaceutica que comprende ciclesonida.
MX359436B (es) Preparacion de combinacion farmaceutica que comprende un inhibidor de hmg-coa reductasa y un inhibidor de la absorcion de colesterol.
GR1008821B (el) Φαρμακευτικο σκευασμα που περιλαμβανει υδροχλωρικη ιβαμπραδινη και μεθοδος παρασκευης αυτου
IN2014CN02343A (en) Oral formulations containing hyaluronic acid for sustained drug release
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
IN2013MU03765A (https=)
MX370184B (es) Composición farmacéutica que comprende fingolimod.
WO2014119984A3 (es) Composición farmacéutica con un sistema bifásico de liberación inmediata para el control de eventos convulsivos y del dolor